Transition Document for the United States Patent and Trademark Office
Summary
This transition document provides over 25 actionable recommendations on the future of the United States Patent and Trademark Office (USPTO), in order to support future federal leadership and enable their success. The document is the result of collaboration between the Day One Project and a group of veteran policymakers who convened virtually to produce recommendations related to the following three categories:
- Identifying specific policy and governance ideas that can be pursued in the first days and months of the next administration.
- Gathering “lessons learned” from those who have previously served in government to learn from past challenges and better inform future initiatives.
- Understanding key science and technology staffing and “talent” needs, and related challenges for the USPTO that can be addressed in the next administration.
The document also includes a cover memo which highlights some of the overarching key considerations for the future of the USPTO.
Contributors
- Margo A. Bagley
- Sharon Barner
- Brian Cassidy
- Colleen V. Chien
- Mark Allen Cohen
- Ayala Deutsch
- Ben Haber
- Philip G. Hampton
- Justin Hughes
- David J. Kappos
- Quentin Palfrey
- Arti K. Rai
- Teresa Stanek Rea
- Robert L. Stoll
- A. Christal Sheppard
- Saurabh Vishnubhakat
- Stephen Yelderman
To better understand what might drive the way we live, learn, and work in 2050, we’re asking the community to share their expertise and thoughts about how key factors like research and development infrastructure and automation will shape the trajectory of the ecosystem.
Recognizing the power of the national transportation infrastructure expert community and its distributed expertise, ARPA-I took a different route that would instead bring the full collective brainpower to bear around appropriately ambitious ideas.
NIH needs to seriously invest in both the infrastructure and funding to undertake rigorous nutrition clinical trials, so that we can rapidly improve food and make progress on obesity.
Modernizing ClinicalTrials.gov will empower patients, oncologists, and others to better understand what trials are available, where they are available, and their up-to-date eligibility criteria, using standardized search categories to make them more easily discoverable.